Xoma | XOMA - Pasivo Circulante





Pasivo Circulante Cambio Fecha
AbbVie USD 42.1B 1.19B 2026-03
Agenus USD 249.24M 74.25M 2026-03
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Ardelyx USD 109.57M 20.96M 2026-03
aTyr Pharma USD 11.7M 101.49M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Celldex Therapeutics USD 51.47M 481K 2026-03
Curis USD 14.08M 5.3M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Incyte USD 1.49B 25.52M 2026-03
MacroGenics USD 95.94M 52.82M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 34.35B 2.64B 2026-03
Prothena USD 32.52M 8.33M 2026-03
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Xoma USD 28.3M 6.81M 2025-09